INTRODUCTION: Patients with dementia may be at a higher risk for death from stroke. We aimed to describe characteristics of dementia patients that died from ischemic stroke (IS) in Sweden. METHODS: A retrospective longitudinal analysis of prospectively collected data of patients registered into the Swedish Dementia Registry was conducted. Data on causes of death, drugs and comorbidities were acquired from the Swedish nationwide health registers. Deaths were attributed to stroke if the death certificate contained stroke as a cause of death and the patient had a stroke registered in Riksstroke, the Swedish Stroke Register, in the year preceding death. Demographic data at the time of dementia diagnosis was compared between patients dying from IS and registered in Riksstroke, patients dying from IS without being registered in Riksstroke and those dying from other causes. RESULTS: Out of 49823 patients diagnosed with dementia between 2007 and 2014 in primary care or specialist clinics, 14170 (28.4%) had died by the end of 2014. Of these 1180 (8.3%) had IS in their death certificate, of which 459 (38.9%) had been registered in Riksstroke. In patients who died of IS the most common type of dementia was vascular dementia while those died from other causes were most often diagnosed with Alzheimer's dementia (AD). Patients who died from IS and were registered in Riksstroke had higher MMSE score compared to other groups. Patients who died from IS took more cardiovascular medications. There were no differences in the use of antipsychotics, antidepressants, acetylcholinesterase inhibitors, memantine, anxiolytics, or hypnotics between the groups. CONCLUSIONS: There was a relatively high number of patients who died from IS as shown in their death certificate but had not been registered in Riksstroke in the year before death. This creates concerns on the accuracy of death certificate stroke diagnoses, particularly for deaths taking place outside hospitals.

Department and Clinical Pharmacology Karolinska University Hospital Stockholm Sweden

Department of Clinical Sciences Lund University Lund Sweden

Department of Geriatric Medicine Huddinge Karolinska University Hospital Stockholm Sweden

Department of Internal Medicine Neurology Section Södersjukhuset Stockholm Sweden

Department of Neurobiology Care Sciences and Society Division of Clinical Geriatrics Karolinska Institutet Stockholm Sweden

Department of Neurobiology Care Sciences and Society Division of Neurogeriatrics Karolinska Institutet Stockholm Sweden

Department of Neurology Lund Skåne University Hospital Lund Sweden

Department of Neurology University Medical Center Ljubljana Slovenia

Departments of Medicine Solna and Clinical Research and Education Karolinska Institutet Södersjukhuset

Medical faculty University of Ljubljana Ljubljana Slovenia

Mossakowski Medical Research Center Polish Academy of Sciences Warsaw Poland

National Institute of Mental Health Klecany Czech Republic

Zobrazit více v PubMed

Lackland D.T., Roccella E.J., Deutsch A.F., Fornage M., George M.G., Howard G., et al. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke. 2014;45(1):315–353. PubMed PMC

Chamandy N., Wolfson C. Underlying cause of death in demented and non-demented elderly Canadians. Neuroepidemiology. 2005;25(2):75–84. PubMed

Subic A., Cermakova P., Norrving B., Winblad B., von Euler M., Kramberger M.G., et al. Management of acute ischaemic stroke in patients with dementia. J. Intern. Med. 2017;281(4):348–364. PubMed

Cermakova P., Szummer K., Johnell K., Fastbom J., Winblad B., Eriksdotter M., et al. Management of acute myocardial infarction in patients with dementia: data from svedem, the swedish dementia registry. J. Am. Med. Dir. Assoc. 2017;18(1):19–23. PubMed

Secnik J., Cermakova P., Fereshtehnejad S.M., Dannberg P., Johnell K., Fastbom J., et al. Diabetes in a large dementia cohort: clinical characteristics and treatment from the swedish dementia registry. Diabetes Care. 2017;40(9):1159–1166. PubMed PMC

Collaborators GMaCoD. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet S0140-6736(14): 61682-2 (2013) 2013 PubMed PMC

Brunnstrom H.R., Englund E.M. Cause of death in patients with dementia disorders. Eur. J. Neurol. 2009;16(4):488–492. PubMed

Kammoun S., Gold G., Bouras C., Giannakopoulos P., McGee W., Herrmann F., et al. Immediate causes of death of demented and non-demented elderly. Acta Neurol. Scand. Suppl. 2000;176:96–99. PubMed

Beard C.M., Kokmen E., Sigler C., Smith G.E., Petterson T., O’Brien P.C. Cause of death in Alzheimer’s disease. Ann. Epidemiol. 1996;6(3):195–200. PubMed

Garcia-Ptacek S., Kareholt I., Cermakova P., Rizzuto D., Religa D., Eriksdotter M. Causes of death according to death certificates in individuals with dementia: a cohort from the swedish dementia registry. J. Am. Geriatr. Soc. 2016;64(11):e137–e42. PubMed

Kukull W.A., Brenner D.E., Speck C.E., Nochlin D., Bowen J., McCormick W., et al. Causes of death associated with Alzheimer disease: variation by level of cognitive impairment before death. J. Am. Geriatr. Soc. 1994;42(7):723–726. PubMed

Staekenborg S.S., Pijnenburg Y.A., Lemstra A.W., Scheltens P., Vd Flier W.M. Dementia and rapid mortality: who is at risk? J. Alzheimers Dis. 2016;53(1):135–142. PubMed

Molsa P.K., Marttila R.J., Rinne U.K. Survival and cause of death in Alzheimer’s disease and multi-infarct dementia. Acta Neurol. Scand. 1986;74(2):103–107. PubMed

Brooke H.L., Talbäck M., Hörnblad J., Johansson L.A., Ludvigsson J.F., Druid H., et al. The Swedish cause of death register. Eur. J. Epidemiol. 2017;32(9):765–773. PubMed PMC

Alpérovitch A., Bertrand M., Jougla E., Vidal J-S., Ducimetière P., Helmer C., et al. Do we really know the cause of death of the very old? Comparison between official mortality statistics and cohort study classification. Eur. J. Epidemiol. 2009;24(11):669. PubMed

Anders E., Hans S., Kristin A., Kurt B., Lars Olov B., Lars Age J., et al. Accuracy of death certificates of cardiovascular disease in a community intervention in Sweden. Scand. J. Public Health. 2013;41(8):883–889. PubMed

Asplund K., Sukhova M., Wester P., Stegmayr B., Riksstroke C. Diagnostic procedures, treatments, and outcomes in stroke patients admitted to different types of hospitals. Stroke. 2015;46(3):806–812. PubMed

Religa D., Fereshtehnejad S.M., Cermakova P., Edlund A.K., Garcia-Ptacek S., Granqvist N., et al. SveDem, the swedish dementia registry - a tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice. PLoS One. 2015;10(2):e0116538. PubMed PMC

Organization W.H. http://apps.who.int/classifications/icd10/browse/2015/en

Asplund K., Hulter Asberg K., Norrving B., Stegmayr B., Terent A., Wester P.O., et al. Riks-stroke - a Swedish national quality register for stroke care. Cerebrovasc. Dis. 2003;15(1):5–7. PubMed

Ludvigsson J.F., Andersson E., Ekbom A., Feychting M., Kim J.L., Reuterwall C., et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450. PubMed PMC

Wettermark B., Hammar N., Fored C.M., Leimanis A., Otterblad Olausson P., Bergman U., et al. The new Swedish Prescribed Drug Register-opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol. Drug Saf. 2007;16(7):726–735. PubMed

Feigin V.L., Krishnamurthi R.V., Parmar P., Norrving B., Mensah G.A., Bennett D.A., et al. Update on the global burden of ischemic and hemorrhagic stroke in 1990-2013: the GBD 2013 study. Neuroepidemiology. 2015;45(3):161–176. PubMed PMC

Vernino S., Brown R.D., Jr, Sejvar J.J., Sicks J.D., Petty G.W., O’Fallon W.M. Cause-specific mortality after first cerebral infarction: a population-based study. Stroke. 2003;34(8):1828–1832. PubMed

Bronnum-Hansen H., Davidsen M., Thorvaldsen P., Danish M.S.G. Long-term survival and causes of death after stroke. Stroke. 2001;32(9):2131–2136. PubMed

Hartmann A., Rundek T., Mast H., Paik M.C., Boden-Albala B., Mohr J.P., et al. Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology. 2001;57(11):2000–2005. PubMed

Moulin S., Leys D. Stroke occurring in patients with cognitive impairment or dementia. Arq. Neuropsiquiatr. 2017;75(2):117–121. PubMed

Lakkireddy D.R., Gowda M.S., Murray C.W., Basarakodu K.R., Vacek J.L. Death certificate completion: how well are physicians trained and are cardiovascular causes overstated? Am. J. Med. 2004;117(7):492–498. PubMed

Lenfant C., Friedman L., Thom T. Fifty years of death certificates: the Framingham Heart Study. Ann. Intern. Med. 1998;129(12):1066–1067. PubMed

Corwin L.E., Wolf P.A., Kannel W.B., McNamara P.M. Accuracy of death certification of stroke: the Framingham Study. Stroke. 1982;13(6):818–821. PubMed

Hallstrom B., Jonsson A.C., Nerbrand C., Norrving B., Lindgren A. Stroke incidence and survival in the beginning of the 21st century in southern Sweden: comparisons with the late 20th century and projections into the future. Stroke. 2008;39(1):10–15. PubMed

Sudlow C.L., Warlow C.P. Comparing stroke incidence worldwide: what makes studies comparable? Stroke. 1996;27(3):550–558. PubMed

Johansson L.A., Westerling R. Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics. Intern J. 2000;29(3):495–502. PubMed

Welfare SBoHa. Nationella riktlinjer för vård vid stroke: Socialstyrelsen. 2017 [cited 2018 27.5.]. Available from: https://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/20618/2017-5-13.pdf.

Hallstrom B., Jonsson A.C., Nerbrand C., Petersen B., Norrving B., Lindgren A. Lund Stroke Register: hospitalization pattern and yield of different screening methods for first-ever stroke. Acta Neurol. Scand. 2007;115(1):49–54. PubMed

Roman G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., et al. Vascular dementia: diagnostic criteria for research studies. Rep NINDS-AIREN Intern Workshop. Neurology. 1993;43(2):250–260. PubMed

Ferrucci L., Guralnik J.M., Salive M.E., Pahor M., Corti M.C., Baroni A., et al. Cognitive impairment and risk of stroke in the older population. J. Am. Geriatr. Soc. 1996;44(3):237–241. PubMed

Imfeld P., Bodmer M., Schuerch M., Jick S.S., Meier C.R. Risk of incident stroke in patients with Alzheimer disease or vascular dementia. Neurology. 2013;81(10):910–919. PubMed

Gorell J.M., Johnson C.C., Rybicki B.A. Parkinson’s disease and its comorbid disorders: an analysis of Michigan mortality data, 1970 to 1990. Neurology. 1994;44(10):1865–1868. PubMed

Struck L.K., Rodnitzky R.L., Dobson J.K. Stroke and its modification in Parkinson’s disease. Stroke. 1990;21(10):1395–1399. PubMed

Levine R.L., Jones J.C., Bee N. Stroke and Parkinson’s disease. Stroke. 1992;23(6):839–842. PubMed

Hobson P., Meara J. Mortality and quality of death certification in a cohort of patients with Parkinson’s disease and matched controls in North Wales, UK at 18 years: a community-based cohort study. BMJ Open. 2018;8(2):e018969 PubMed PMC

Fereshtehnejad S.M., Damangir S., Cermakova P., Aarsland D., Eriksdotter M., Religa D. Comorbidity profile in dementia with Lewy bodies versus Alzheimer’s disease: a linkage study between the Swedish Dementia Registry and the Swedish National Patient Registry. Alzheimers Res. Ther. 2014;6(5-8):65. PubMed PMC

Jellinger K.A. Prevalence of vascular lesions in dementia with Lewy bodies. A postmortem study. J. Neural Transm. (Vienna) 2003;110(7):771–778. PubMed

Kalkonde Y.V., Jawaid A., Qureshi S.U., Shirani P., Wheaton M., Pinto-Patarroyo G.P., et al. Medical and environmental risk factors associated with frontotemporal dementia: a case-control study in a veteran population. Alzheimers Dement. 2012;8(3):204–210. PubMed

Weich S., Pearce H.L., Croft P., Singh S., Crome I., Bashford J., et al. Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study. BMJ. 2014;348:g1996. PubMed PMC

Wooltorton E. Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials. CMAJ. 2002;167(11):1269–1270. PubMed PMC

Zhang J.P., Gallego J.A., Robinson D.G., Malhotra A.K., Kane J.M., Correll C.U. Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int. J. Neuropsychopharmacol. 2013;16(6):1205–1218. PubMed PMC

Gill S.S., Bronskill S.E., Normand S.L., Anderson G.M., Sykora K., Lam K., et al. Antipsychotic drug use and mortality in older adults with dementia. Ann. Intern. Med. 2007;146(11):775–786. PubMed

Mittal V., Kurup L., Williamson D., Muralee S., Tampi R.R. Risk of cerebrovascular adverse events and death in elderly patients with dementia when treated with antipsychotic medications: a literature review of evidence. Am. J. Alzheimers Dis. Other Demen. 2011;26(1):10–28. PubMed PMC

Norgaard A., Jensen-Dahm C., Gasse C., Hansen H.V., Waldemar G. Time trends in antipsychotic drug use in patients with dementia: a nationwide study. J. Alzheimers Dis. 2015 PubMed

Nerius M., Johnell K., Garcia-Ptacek S., Eriksdotter M., Haenisch B., Doblhammer G. The impact of antipsychotic drugs on long-term care, nursing home admission and death among dementia patients. J. Gerontol. A Biol. Sci. Med. Sci. 2017 PubMed PMC

Asplund K., Lundström S., Stegmayr B. End of life after stroke: a nationwide study of 42,502 deaths occurring within a year after stroke. Eur Stroke J. 2018;3(1):74–81. PubMed PMC

Garcia-Ptacek S., Farahmand B., Kareholt I., Religa D., Cuadrado M.L., Eriksdotter M. Mortality risk after dementia diagnosis by dementia type and underlying factors: a cohort of 15,209 patients based on the swedish dementia registry. J. Alzheimers Dis. 2014;41(2):467–477. PubMed

Department of Health and Human Services Centers for Disease Control and Prevention, National Center for Health Statistics. Physicians’ handbook on medical certification of death. Hyattsville, Maryland: Government Printing Office; 2003.

Hospitalizations and Mortality of Individuals with Dementia: Evidence from Czech National Registers